X
Indivior hit hard as generic Suboxone defence crumbles
https://pharmaphorum.com/news/indivior-hit-hard-as-generic-suboxone-defence-crumbles/
patent
Biogen gets go-ahead for EU Humira launch in October
But deal with Samsung prevents US launch until mid-2023
US judge overturns Gilead $2.54bn patent infringement ruling
Federal judge throws out Merck’s patent claim against Gilead
Zytiga is powerhouse for J&J – but for how long?
J&J to ‘vigorously defend’ blockbuster’s patent
Judge throws out Allergan patents, criticises Native American tribe deal
Federal court throws out patents on Restasis
US lawmaker moves to block Allergan patent deal with tribe
Senator Claire McCaskill says deal exploits a “brazen loophole”.
Native American tribe open to more patent deals with pharma
Saint Regis Mohawk Tribe expects more interest from pharma after Allergan deal.
Silence Therapeutics takes rival Alnylam to court in patent fight
Silence claims late-stage drugs infringe patents.
